vs
MANNATECH INC（MTEX）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
MANNATECH INC的季度营收约是ROCKWELL MEDICAL, INC.的1.6倍（$29.2M vs $18.3M），MANNATECH INC净利率更高（6.6% vs -3.0%，领先9.6%），MANNATECH INC同比增速更快（-8.1% vs -25.6%），ROCKWELL MEDICAL, INC.自由现金流更多（$2.2M vs $-2.0M），过去两年MANNATECH INC的营收复合增速更高（-5.4% vs -10.1%）
曼纳泰克是一家公开上市的跨国多层次直销企业，主营膳食补充剂与个人护理产品，由塞缪尔·卡斯特于1993年11月创立，总部位于美国德克萨斯州花丘，股票在纳斯达克挂牌交易。截至2017年，公司共有252名雇员，产品通过约22万名独立销售代理推广销售。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
MTEX vs RMTI — 直观对比
营收规模更大
MTEX
是对方的1.6倍
$18.3M
营收增速更快
MTEX
高出17.5%
-25.6%
净利率更高
MTEX
高出9.6%
-3.0%
自由现金流更多
RMTI
多$4.2M
$-2.0M
两年增速更快
MTEX
近两年复合增速
-10.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $29.2M | $18.3M |
| 净利润 | $1.9M | $-554.0K |
| 毛利率 | 76.4% | 21.1% |
| 营业利润率 | 6.9% | -2.2% |
| 净利率 | 6.6% | -3.0% |
| 营收同比 | -8.1% | -25.6% |
| 净利润同比 | 686.6% | 26.7% |
| 每股收益（稀释后） | $1.01 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MTEXRMTI
| Q4 25 | — | $18.3M | ||
| Q3 25 | $29.2M | $15.9M | ||
| Q2 25 | — | $16.1M | ||
| Q1 25 | $26.6M | $18.9M | ||
| Q4 24 | $29.0M | $24.7M | ||
| Q3 24 | $31.7M | $28.3M | ||
| Q2 24 | $27.7M | $25.8M | ||
| Q1 24 | $29.4M | $22.7M |
净利润MTEXRMTI
| Q4 25 | — | $-554.0K | ||
| Q3 25 | $1.9M | $-1.8M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | $-1.5M | $-1.5M | ||
| Q4 24 | $2.3M | $-756.0K | ||
| Q3 24 | $-328.0K | $1.7M | ||
| Q2 24 | $-624.0K | $343.0K | ||
| Q1 24 | $1.2M | $-1.7M |
毛利率MTEXRMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | 76.4% | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | 74.3% | 16.1% | ||
| Q4 24 | 80.6% | 14.7% | ||
| Q3 24 | 74.5% | 22.0% | ||
| Q2 24 | 77.1% | 17.6% | ||
| Q1 24 | 78.6% | 13.5% |
营业利润率MTEXRMTI
| Q4 25 | — | -2.2% | ||
| Q3 25 | 6.9% | -9.9% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | -3.1% | -7.2% | ||
| Q4 24 | 3.0% | -2.1% | ||
| Q3 24 | 2.8% | 6.8% | ||
| Q2 24 | -4.1% | 2.0% | ||
| Q1 24 | 2.8% | -5.8% |
净利率MTEXRMTI
| Q4 25 | — | -3.0% | ||
| Q3 25 | 6.6% | -11.0% | ||
| Q2 25 | — | -9.3% | ||
| Q1 25 | -5.8% | -8.0% | ||
| Q4 24 | 7.8% | -3.1% | ||
| Q3 24 | -1.0% | 5.9% | ||
| Q2 24 | -2.2% | 1.3% | ||
| Q1 24 | 4.0% | -7.6% |
每股收益（稀释后）MTEXRMTI
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $1.01 | $-0.05 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | $-0.80 | $-0.04 | ||
| Q4 24 | $1.19 | $-0.02 | ||
| Q3 24 | $-0.17 | $0.04 | ||
| Q2 24 | $-0.33 | $0.01 | ||
| Q1 24 | $0.63 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.1M | $10.7M |
| 总债务越低越好 | $2.9M | — |
| 股东权益账面价值 | $7.0M | $37.0M |
| 总资产 | $33.9M | $57.1M |
| 负债/权益比越低杠杆越低 | 0.42× | — |
8季度趋势，按日历期对齐
现金及短期投资MTEXRMTI
| Q4 25 | — | $10.7M | ||
| Q3 25 | $7.1M | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | $9.3M | $11.4M | ||
| Q4 24 | $11.4M | $15.7M | ||
| Q3 24 | $12.2M | $12.3M | ||
| Q2 24 | $9.2M | $11.9M | ||
| Q1 24 | $7.9M | $6.6M |
总债务MTEXRMTI
| Q4 25 | — | — | ||
| Q3 25 | $2.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MTEXRMTI
| Q4 25 | — | $37.0M | ||
| Q3 25 | $7.0M | $37.0M | ||
| Q2 25 | — | $30.4M | ||
| Q1 25 | $7.6M | $31.5M | ||
| Q4 24 | $8.6M | $32.6M | ||
| Q3 24 | $10.0M | $29.1M | ||
| Q2 24 | $8.2M | $23.5M | ||
| Q1 24 | $10.4M | $20.6M |
总资产MTEXRMTI
| Q4 25 | — | $57.1M | ||
| Q3 25 | $33.9M | $57.5M | ||
| Q2 25 | — | $52.6M | ||
| Q1 25 | $36.7M | $54.0M | ||
| Q4 24 | $36.1M | $59.2M | ||
| Q3 24 | $40.6M | $57.1M | ||
| Q2 24 | $39.9M | $53.0M | ||
| Q1 24 | $41.1M | $50.7M |
负债/权益比MTEXRMTI
| Q4 25 | — | — | ||
| Q3 25 | 0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.3M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $-2.0M | $2.2M |
| 自由现金流率自由现金流/营收 | -6.8% | 12.0% |
| 资本支出强度资本支出/营收 | 2.4% | 0.5% |
| 现金转化率经营现金流/净利润 | -0.68× | — |
| 过去12个月自由现金流最近4个季度 | $-1.2M | $-1.2M |
8季度趋势，按日历期对齐
经营现金流MTEXRMTI
| Q4 25 | — | $2.3M | ||
| Q3 25 | $-1.3M | $-1.3M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | $-1.4M | $-3.5M | ||
| Q4 24 | $-219.0K | $865.0K | ||
| Q3 24 | $3.3M | $4.3M | ||
| Q2 24 | $-2.7M | $1.4M | ||
| Q1 24 | $1.9M | $-2.4M |
自由现金流MTEXRMTI
| Q4 25 | — | $2.2M | ||
| Q3 25 | $-2.0M | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | $-1.9M | $-3.5M | ||
| Q4 24 | $-325.0K | $470.0K | ||
| Q3 24 | $3.0M | $4.1M | ||
| Q2 24 | $-2.7M | $1.2M | ||
| Q1 24 | $1.8M | $-2.5M |
自由现金流率MTEXRMTI
| Q4 25 | — | 12.0% | ||
| Q3 25 | -6.8% | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | -7.0% | -18.8% | ||
| Q4 24 | -1.1% | 1.9% | ||
| Q3 24 | 9.5% | 14.4% | ||
| Q2 24 | -9.9% | 4.5% | ||
| Q1 24 | 6.2% | -11.1% |
资本支出强度MTEXRMTI
| Q4 25 | — | 0.5% | ||
| Q3 25 | 2.4% | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | 1.8% | 0.3% | ||
| Q4 24 | 0.4% | 1.6% | ||
| Q3 24 | 0.8% | 0.7% | ||
| Q2 24 | 0.3% | 1.1% | ||
| Q1 24 | 0.2% | 0.6% |
现金转化率MTEXRMTI
| Q4 25 | — | — | ||
| Q3 25 | -0.68× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.10× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | 1.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTEX
暂无分部数据
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
